Active surveillance provides an important alternative to immediate treatment for early-stage, low-ri Investigators from the phase 3 ARAMIS trial reported a significant delay in PSA progression in ...
Expert perspectives on the treatment approach for patients with metastatic castrate-resistant prostate cancer. This is a synopsis of an Educated Patient Sound Bites series featuring Alicia Morgans, MD ...
Accuracy of a simplified sequencing and bioinformatics platform on genetic variant detection in patients with prostate cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results